534 results on '"Musiał, Jacek"'
Search Results
2. Toward harmonized interpretation of anticardiolipin and anti–β2-glycoprotein I antibody detection for diagnosis of antiphospholipid syndrome using defined level intervals and likelihood ratios: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
3. A thrombin-driven neural net diagnoses the antiphospholipid syndrome without the need for interruption of anticoagulation
4. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of obstetric antiphospholipid syndrome: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
5. Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5
6. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
7. Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
8. Relapse Predictors in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis.
9. Increased interest with the introduction of fast-track diagnostic pathway is associated with the regionally increased frequency of giant cell arteritis in Poland: a study based on POLVAS registry data.
10. Vibro-acoustic response of spacecraft instrument subjected to diffuse sound field: Numerical simulations and experimental verification
11. Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study
12. Clinical Characteristics of EGPA Patients in Comparison to GPA Subgroup with Increased Blood Eosinophilia from POLVAS Registry
13. Differences in Staining for Neutrophil Elastase and its Controlling Inhibitor SLPI Reveal Heterogeneity among Neutrophils in Psoriasis
14. Treatment and its side effects in ANCA-associated vasculitides – Study based on POLVAS registry data
15. Detection of anti‐domain I antibodies by chemiluminescence enables the identification of high‐risk antiphospholipid syndrome patients: A multicenter multiplatform study
16. The (non‐)sense of detecting anti‐cardiolipin and anti‐β2glycoprotein I IgM antibodies in the antiphospholipid syndrome
17. Serum IL-17 and TNFα as prognostic biomarkers in systemic sclerosis patients: a prospective study
18. Antiphosphatidylserine/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome
19. Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification
20. Identification and prospective stability of electronic nose (eNose)–derived inflammatory phenotypes in patients with severe asthma
21. Patients with small-vessel vasculitides have the highest mortality among systemic autoimmune diseases patients treated in intensive care unit: A retrospective study with 5-year follow-up
22. Polskie zalecenia postępowania w pierwotnej małopłytkowości immunologicznej u dorosłych opracowane przez Grupę ds. Hemostazy Polskiego Towarzystwa Hematologów i Transfuzjologów -- aktualizacja 2024.
23. Polish recommendations for the management of ITP in adults developed by the Hemostasis Group of the Polish Society of Hematologists and Transfusiologists -- update 2024.
24. Association between clinical features and course of systemic sclerosis and serum interleukin-8, vascular endothelial growth factor, basic fibroblast growth factor, and interferon alpha.
25. Nowe kryteria klasyfikacyjne zespołu antyfosfolipidowego — 2023
26. New classification criteria for antiphospholipid syndrome — 2023
27. Activity of granulomatosis with polyangiitis and its correlation with mTOR phosphoproteomics in neutrophils
28. Association between clinical features and course of systemic sclerosis and serum interleukin-8, vascular endothelial growth factor, basic fibroblast growth factor, and interferon alpha
29. Myocardial Injury is More Common than Deep Venous Thrombosis after Vascular Surgery and is Associated with a High One Year Mortality Risk
30. Clinical characteristics of Polish patients with ANCA-associated vasculitides—retrospective analysis of POLVAS registry
31. Część II: Wytyczne postępowania w hemofilii A i B powikłanej inhibitorem czynnika VIII i IX (2 wydanie)
32. Endothelial dysfunction in patients with granulomatosis with polyangiitis: a case–control study
33. Influence of autoimmunity and inflammation on endothelial function and thrombosis in systemic lupus erythematosus patients
34. Design and acoustic tests of the ATHENA WFI filter wheel assembly development model towards TRL5
35. Decreased protein C activity, lower ADAMTS13 antigen and free protein S levels accompanied by unchanged thrombin generation potential in hospitalized COVID-19 patients
36. Część I: Wytyczne postępowania w hemofilii A i B niepowikłanej inhibitorem czynnika VIII i IX (wydanie zaktualizowane)
37. Thrombophilia and ischemic stroke.
38. Trombofilia a niedokrwienny udar mózgu.
39. Factor XI inhibitors — a breakthrough in prevention and treatment of thromboembolic disorders
40. Angiosarcoma of the lungs, liver, and bones in a 27-year-old male patient
41. Venous thromboembolism and antithrombotic therapy in COVID-19
42. Congenital/inherited thrombophilia in adults — characteristics, laboratory testing and management. Recommendations of the Hemostasis Group of the Polish Society of Hematology and Transfusiology 2022
43. Risk factors for arterial thrombosis in antiphospholipid syndrome
44. Neural Network Diagnoses the Antiphospholipid Syndrome without Interrupting Anticoagulant Therapy
45. Leiomyosarcoma of inferior vena cava complicated by Budd-Chiari syndrome and disseminated intravascular coagulation — case report
46. Application of bidirectional rapidly exploring random trees (BiRRT) algorithm for collision-free trajectory planning of free-floating space manipulator
47. Management of von Willebrand disease. Recommendations of the Hemostasis Group of the Polish Society of Hematology and Transfusiology (2022)
48. DOAC — not for everyone, and sometimes at different dose
49. Genetic Association between TNFA Polymorphisms (rs1799964 and rs361525) and Susceptibility to Cancer in Systemic Sclerosis
50. Clinical study on single-organ cutaneous small vessels vasculitis (SoCSVV)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.